Teva returns to the market after opioid controversy with USD/EUR dual-tranche
20 Nov 2019Teva Pharmaceutical (Ba2/BB/BB) returned to the international markets yesterday (19 November) with a dual tranche USD/EUR for a combined size of USD2.1bn, equivalent. The company has had a challenging year as it attempted to mitigate its connection